Starton Therapeutics (Starton Therapeutics) Current Accrued Expense : $0.27 Mil (As of Jun. 2023)

View and export this data going back to 2050. Start your Free Trial

What is Starton Therapeutics Current Accrued Expense?

Starton Therapeutics's Current Accrued Expense for the quarter that ended in Jun. 2023 was $0.27 Mil.

Starton Therapeutics's quarterly Current Accrued Expense increased from Dec. 2022 ($0.02 Mil) to Mar. 2023 ($0.25 Mil) and increased from Mar. 2023 ($0.25 Mil) to Jun. 2023 ($0.27 Mil).

Starton Therapeutics's annual Current Accrued Expense increased from Mar. 2021 ($0.13 Mil) to Mar. 2022 ($0.13 Mil) and increased from Mar. 2022 ($0.13 Mil) to Mar. 2023 ($0.25 Mil).

Starton Therapeutics Current Accrued Expense Historical Data

The historical data trend for Starton Therapeutics's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Starton Therapeutics Current Accrued Expense Chart

Starton Therapeutics Annual Data

Trend

Mar21

Mar22

Mar23

Current Accrued Expense

0.13

0.25

Starton Therapeutics Quarterly Data
	Mar21	Dec21	Mar22	Jun22	Dec22	Mar23	Jun23
Current Accrued Expense	Get a 7-Day Free Trial			0.13	-	0.02	0.25	0.27

Starton Therapeutics Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Starton Therapeutics Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Starton Therapeutics's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Starton Therapeutics (Starton Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Starton Therapeutics Inc (NAS:STA) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

215 College Road, Suite No.300, Paramus, NJ, USA, 07652

Website

https://www.startontx.com

Starton Therapeutics Inc is a clinical-stage biotechnology company transforming standard-of-care therapies with proprietary continuous delivery technology, so people with cancer can receive continuous treatment to live better, and longer. Starton's proprietary continuous delivery technology can increase the efficacy of approved drugs, make them more tolerable, and expand their potential use.

Starton Therapeutics (Starton Therapeutics) Headlines

No Headlines